Company registration number:
The Manor Drug Company (Nottingham) Limited
for the Year Ended 30 November 2023
The Manor Drug Company (Nottingham) Limited
Contents
Company Information |
|
Balance Sheet |
|
Notes to the Financial Statements |
The Manor Drug Company (Nottingham) Limited
Company Information
Directors |
Mr G A Tims Mrs A J Cattee Mr P Cattee |
Registered office |
|
Auditors |
|
The Manor Drug Company (Nottingham) Limited
(Registration number: 00923390)
Balance Sheet as at 30 November 2023
Note |
2023 |
2022 |
|
Fixed assets |
|||
Tangible assets |
- |
|
|
Current assets |
|||
Stocks |
- |
|
|
Debtors |
|
|
|
Cash at bank and in hand |
- |
|
|
|
|
||
Creditors: Amounts falling due within one year |
- |
( |
|
Net current assets |
|
|
|
Net assets |
|
|
|
Capital and reserves |
|||
Called up share capital |
|
|
|
Retained earnings |
- |
|
|
Shareholders' funds |
|
|
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.
Approved and authorised by the
......................................... |
The Manor Drug Company (Nottingham) Limited
Notes to the Financial Statements for the Year Ended 30 November 2023
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
England
These financial statements were authorised for issue by the
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
Basis of preparation
These financial statements have been prepared using the historical cost convention.
The financial statements are prepared in sterling , which is the functional currency of the entity.
Going concern
At 1 December 2022 the directors took the decision to hive-up the trade and assets of the company to PCT Healthcare Limited, a parent undertaking, and to then cease to trade.
Accordingly the directors have not prepared the financial statements on a going concern basis.
The Manor Drug Company (Nottingham) Limited
Notes to the Financial Statements for the Year Ended 30 November 2023
Audit report
Revenue recognition
Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.
Tangible assets
Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation
Depreciation is charged so as to write off the cost of assets over their estimated useful lives, as follows:
Asset class |
Depreciation method and rate |
Plant and machinery |
20% reducing balance |
Fixtures and fittings |
10-20% reducing balance |
Computer equipment |
20% reducing balance |
Stocks
Stocks are stated at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items.
Leases
Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.
Defined contribution pension obligation
A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.
The Manor Drug Company (Nottingham) Limited
Notes to the Financial Statements for the Year Ended 30 November 2023
Staff numbers |
The average number of persons employed by the company (including directors) during the year, was
Tangible assets |
Fixtures and fittings |
Plant and machinery |
Office equipment |
Total |
|
Cost or valuation |
||||
At 1 December 2022 |
|
|
|
|
Disposals |
( |
( |
( |
( |
At 30 November 2023 |
- |
- |
- |
- |
Depreciation |
||||
At 1 December 2022 |
|
|
|
|
Eliminated on disposal |
( |
( |
( |
( |
At 30 November 2023 |
- |
- |
- |
- |
Carrying amount |
||||
At 30 November 2023 |
- |
- |
- |
- |
At 30 November 2022 |
|
|
|
|
Debtors |
2023 |
2022 |
||
Trade debtors |
- |
|
|
Amounts owed by group undertakings |
|
- |
|
Prepayments and accrued income |
- |
|
|
Other debtors |
- |
|
|
|
|
The Manor Drug Company (Nottingham) Limited
Notes to the Financial Statements for the Year Ended 30 November 2023
Creditors |
Creditors: amounts falling due within one year
2023 |
2022 |
||
Due within one year |
|||
Trade creditors |
- |
|
|
Amounts owed to group undertakings |
- |
|
|
Accruals and deferred income |
- |
|
|
- |
|
Financial commitments, guarantees and contingencies |
Amounts not provided for in the balance sheet
The total amount of contingencies not included in the balance sheet is £39,720,000 (2022 - £33,461,733).
Parent and ultimate parent undertaking |
The company's immediate parent is
The ultimate parent is
These financial statements are available upon request from Companies House, Crown Way, Maindy, Cardiff CF14 3UZ